Sam Cobb

Sam is the founding CEO of Currus Biologics. Sam has over 25 years’ experience in business development and commercialisation with a focus on biologics. Prior to Currus Biologics, Sam was the founding CEO of AdAlta (ASX: 1AD), where Sam saw AdAlta through several transitions over a 12-year period including listing the company on the ASX. Sam led the development of AdAlta’s novel biologics platform from idea to a Phase I-ready lead candidate and secured multiple big pharma and biotech deals with its platform. Sam has worked for several biotech companies and technology transfer companies, focused on the commercialisation of life-science opportunities. Sam worked at the lab bench at Agen Biomedical as a research scientist, developing a diagnostic test for point of care application, taking the test from research through development and to production. Sam has a Bachelor of Science and a Masters of Intellectual Property Law and has completed the Australian Institute of Company Directors course.